Cargando…
Chemokine receptor expression in tumour islets and stroma in non-small cell lung cancer
BACKGROUND: We have previously demonstrated that tumour islet infiltration by macrophages is associated with extended survival (ES) in NSCLC. We therefore hypothesised that patients with improved survival would have high tumour islet expression of chemokine receptors known to be associated with favo...
Autores principales: | Ohri, Chandra M, Shikotra, Aarti, Green, Ruth H, Waller, David A, Bradding, Peter |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2876080/ https://www.ncbi.nlm.nih.gov/pubmed/20429924 http://dx.doi.org/10.1186/1471-2407-10-172 |
Ejemplares similares
-
Tumour necrosis factor-alpha expression in tumour islets confers a survival advantage in non-small cell lung cancer
por: Ohri, Chandra M, et al.
Publicado: (2010) -
The Tissue Microlocalisation and Cellular Expression of CD163, VEGF, HLA-DR, iNOS, and MRP 8/14 Is Correlated to Clinical Outcome in NSCLC
por: Ohri, Chandra M., et al.
Publicado: (2011) -
Correction: The Tissue Microlocalisation and Cellular Expression of CD163, VEGF, HLA-DR, iNOS, and MRP 8/14 Is Correlated to Clinical Outcome in NSCLC
por: Ohri, Chandra M., et al.
Publicado: (2011) -
Mast cell phenotype, TNFα expression and degranulation status in non-small cell lung cancer
por: Shikotra, A., et al.
Publicado: (2016) -
Expression of the chemokine CXCL14 in the tumour stroma is an independent marker of survival in breast cancer
por: Sjöberg, Elin, et al.
Publicado: (2016)